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Bone marrow transplantation is the primary therapy
for numerous hematopoietic disorders. The effi-
ciency of bone marrow transplantation depends on
the function of long-term hematopoietic stem cells
(LT-HSCs), which is markedly influenced by their
hypoxic niche. Survival in this low-oxygenmicroenvi-
ronment requires significant metabolic adaptation.
Here, we show that LT-HSCs utilize glycolysis
instead of mitochondrial oxidative phosphorylation
to meet their energy demands. We used flow cytom-
etry to identify a unique low mitochondrial activity/
glycolysis-dependent subpopulation that houses the
majority of hematopoietic progenitors and LT-HSCs.
Finally, we demonstrate that Meis1 and Hif-1a are
markedly enriched in LT-HSCs and that Meis1
regulates HSC metabolism through transcriptional
activation of Hif-1a. These findings reveal an impor-
tant transcriptional network that regulates HSC
metabolism.
INTRODUCTION
The microenvironment, or niche, plays a crucial role in self-
renewal and differentiation of hematopoietic stem cells (HSCs)
(Fuchs et al., 2004; Spradling et al., 2001). One of the hallmarks
of the HSC niche is its low-oxygen tension, hence the term
‘‘hypoxic niche’’ (Chow et al., 2001a; Parmar et al., 2007). This
low-oxygen environment is not only tolerated by HSCs,
but also appears to be essential for their function (Bradley
et al., 1978; Chow et al., 2001a; Cipolleschi et al., 1993; Danet
et al., 2003; Eliasson and Jo¨nsson, 2010; Katahira and
Mizoguchi, 1987; Koller et al., 1992; Kubota et al., 2008; LaIuppa
et al., 1998; Lo Celso et al., 2009; Parmar et al., 2007). Themech-
anism of this hypoxic tolerance of HSCs, while poorly under-
stood, requires significant metabolic adaptation.380 Cell Stem Cell 7, 380–390, September 3, 2010 ª2010 Elsevier InHif-1 is a master regulator of metabolism. It regulates both
glycolysis and mitochondrial respiration, inducing a metabolic
shift toward anaerobic glycolysis (Ha¨gg and Wennstro¨m, 2005;
Kim et al., 2006b; Marı´n-Herna´ndez et al., 2009; Maxwell et al.,
2007; Papandreou et al., 2006; Wang et al., 1995; Zhang et al.,
2007). Hif-1 function is dependent on dimerization of the consti-
tutively active Hif-1b subunit and the tightly regulated Hif-1a
subunit. Hif-1a undergoes hydroxylation, followed by ubiquitina-
tion and degradation during normoxia in most cells (Ivan et al.,
2001; Jaakkola et al., 2001; Kamura et al., 2000; Maxwell et al.,
1999; Salceda and Caro, 1997). Upregulation of Hif-1a can occur
either by transcriptional activation (Hirota et al., 2004; Laughner
et al., 2001) or protein stabilization (Li et al., 2005; Nakayama
et al., 2004; Qi et al., 2008; Semenza, 2007). Several studies
have demonstrated that Hif-1a may play a crucial role in HSCs
(Iyer et al., 1998; Ryan et al., 1998) (Kim et al., 2006a); however,
the function and mechanism of regulation of Hif-1a in HSCs
remain largely unknown.
Meis1 belongs to the Hox family of homeobox genes, which
is an evolutionarily conserved set of genes that encode
DNA-binding transcription factors (Krumlauf, 1994). Meis1 is
expressed in the most primitive hematopoietic populations
and is downregulated upon differentiation (Argiropoulos et al.,
2007; Imamura et al., 2002; Pineault et al., 2002). Moreover, tar-
geted Meis1 knockout causes lethality by embryonic day 14.5
with multiple hematopoietic and vascular defects (Azcoitia
et al., 2005; Hisa et al., 2004; Imamura et al., 2002). Despite
the clear association of Meis1 with HSCs, the precise function
of Meis1 in HSCs is not well understood.
In the current study, we outline the unique metabolic charac-
teristics of LT-HSCs and we show that separation of bone
marrow cells solely based on their metabolic footprint markedly
enriches for HSCs. Finally, we demonstrate that Meis1 regulates
HSC metabolism through transcriptional activation of Hif-1a.
RESULTS
Metabolic Profile of Mouse LT-HSCs
Lin, Sca-1+, c-Kit+, CD34, and Flk2 (LT-HSCs) cells have low
rates of mitochondrial respiration (Figure 1A) and low levels ofc.
Figure 1. Metabolic Profile of Mouse HSCs
(A) Oxygen consumption of Lin, SCA-1+, c-Kit+, CD34, and Flk2 cells (LT-HSCs) and whole bone marrow demonstrating lower rates of oxygen consumption
by LT-HSCs (n = 3).
(B) ATP level of LT-HSCs and whole bone marrow demonstrating lower ATP levels in LT-HSCs (n = 3).
(C) Glycolytic flux of LT-HSCs and whole bone marrow demonstrating higher rates of glycolysis in LT-HSCs (n = 3).
(D) Flow cytometry profile of whole mouse bone marrow stained with mitotracker. Note the distinct populations with different mitotracker fluorescence.
(E) Mitotracker profile of LT-HSCs. The majority of LT-HSCs (84%–86%) are localized to a distinct population (6%–9% of total bone marrow cells) with low mito-
chondrial potential (MP cells).
(F) Mitotracker profile of different bonemarrow lineages. Note that whereas the majority of LT-HSCs and LSK cells are localized to the lowmitochondrial potential
gate, the majority of all other lineages have high mitochondrial potential (n = 4).
(G) Lineage composition of the low MP cells. Note that whereas the low MP gate is markedly enriched in LT-HSCs and LSK cells, it also contains all other bone
marrow lineages (n = 4).
(H) Percentage of cells in the low MP gate following pretreatment with FTC (a specific blocker of the ABCG2 transporter). Note that FTC had no effect on the
percentage of cells in the low MP gate (n = 3). This indicates that the low MP profile is not secondary to dye efflux. Data presented as mean ± SEM.
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Meis1 Regulates HSC MetabolismATP (Figure 1B). Lower rates of mitochondrial respiration can be
attributed to lower energy requirements (i.e., quiescence) and/or
utilization of glycolysis instead of oxidative phosphorylation.CellTherefore, we examined the overall glycolytic flux as determined
by the rate of glucose-derived 13C lactate production. As shown
in Figure 1C, the rate of glucose-derived 13C lactate productionStem Cell 7, 380–390, September 3, 2010 ª2010 Elsevier Inc. 381
Figure 2. Low MP Cells Are Glycolytic
(A) Comparison between mitotracker fluorescence and endogenous NADH fluorescence of both high MP and low MP cells. Note the direct correlation between
mitotracker fluorescence and NADH fluorescence, which provides further proof of the metabolic state of these two populations (n = 4).
(B) Oxygen consumption of high and low MP cells. Note the significantly lower rates oxygen consumption in the low MP cells (n = 3).
(C) ATP content of high and low MP cells demonstrating a significantly lower levels of ATP in the low MP cells (n = 3).
(D) Measurement of glycolytic flux of high and low MP cells as determined by 13C-Lactate production. The low MP cells displayed significantly higher rates of
glycolysis/nMol ATP compared to the high MP cells (n = 3).
(E) Determination of cellular source of NADH: flow cytometry profiles of high (upper) and low (lower) MP cells before (left) and after (right) treatment with antimycin
A (AMA). Note the significant shift of most of the high MP cells after AMA treatment (upper right panel) and the minimal shift of low MP cells in response to AMA
(lower right panel). The bar graph shows quantification of the percentage of cells with increasedNADH fluorescence in response to AMA (n = 3). This indicates that
the majority of NADH in the low MP cells is derived from nonmitochondrial source(s). Data presented as mean ± SEM.
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Meis1 Regulates HSC Metabolismwas higher in LT-HSCs compared to whole bone marrow when
normalized to cellular ATP. This method determines the source
of lactate and not only the amount of lactate produced. This is
important because cells can produce lactate from the metabo-
lism of glutamine rather than glucose (DeBerardinis et al., 2007).
Next, we determined the metabolic profile of LT-HSCs by flow
cytometry. Whole mouse bone marrow underwent lineage
depletion, then was concomitantly stained for Sca-1+, c-Kit+,
CD34, and Flk2 surface expression and for mitotracker incor-
poration. Cells were also assessed for endogenous NADH fluo-
rescence. These techniques allow profiling of cells based on382 Cell Stem Cell 7, 380–390, September 3, 2010 ª2010 Elsevier Intheir mitochondrial proton gradient in the case of mitotracker
(Poot et al., 1996) and endogenous NADH fluorescence (Chance
and Thorell, 1959) as an index of overall mitochondrial respiration
(as the majority of cellular NADH is derived from mitochondrial
respiration). The majority of LT-HSCs were localized to a well-
defined flow cytometry gate, which contained 6%–9% of total
bone marrow cells. Cells in this gate were characterized by
low mitochondrial potential (MP) (Figures 1D and 1E) and low
NADH fluorescence (Figure 2A). This low MP population con-
tained >80% of LT-HSCs (Figure 1F). Lineage characterization
of the low MP population demonstrated that LT-HSCs andc.
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Meis1 Regulates HSC MetabolismLineage, Sca-1+, c-Kit+ (LSK) cells are the only two populations
that are largely localized to the low MP gate, whereas all other
lineages had mostly high mitochondrial potential (Figure 1F).
Moreover, this low MP gate, although markedly enriched in
LT-HSCs and LSK cells, contains all other bonemarrow lineages
(Figure 1G). To exclude the possibility that this low mitotracker
profile is secondary to dye efflux, we used Fumitremorgin C
(FTC), a specific blocker of the ABCG2 transporter. The ABCG2
transporter is responsible for dye efflux by the side population
(SP) stem cells (Goodell et al., 1997; Scharenberg et al., 2002;
Zhou et al., 2001). As shown in Figure 1H, FTC had no effect
on the percentage of cells in the low MP gate.
Metabolic Characteristics of High and Low MP Cells
Wenext characterized themetabolic properties of cells in the low
MP gate as they compare to cells with high MP. First, we directly
correlated endogenous NADH fluorescence with mitotracker
fluorescence. NADH fluorescence is an index of mitochondrial
oxidative phosphorylation given that oxidativemetabolism yields
a significantly higher amount of NADH for each molecule of
glucose oxidized when compared to glycolysis (eight molecules
NADH compared to two molecules, respectively) (Chance and
Thorell, 1959). As shown in Figure 2A, high and low mitotracker
cells displayed high and low NADH fluorescence cells, respec-
tively. This result is supported by measurement of oxygen
consumption, where the high MP cells displayed significantly
higher oxygen consumption rates compared to the low MP cells
(Figure 2B).
Low MP cells also preferentially utilized glycolysis for their
metabolic needs. As shown in Figure 2D, the rate of 13C lactate
production was significantly higher in the low MP cells. We
further confirmed this finding by using a specific mitochondrial
electron transport chain inhibitor. Inhibition of the electron trans-
port chain complex III by antimycin A (AMA) results in NADH
accumulation only in cells that rely on mitochondrial respiration
for NADH production. We used this principle to evaluate the
source of NADH in high and low MP cells. As shown in
Figure 2E, only a small percentage of the low MP cells displayed
increased NADH after AMA treatment compared to high MP
cells, indicating that mitochondrial respiration is not the main
source of NADH in low MP cells. Taken together, these results
indicate that the low MP cells do not rely on mitochondrial
respiration for energy production, but rather on cytoplasmic
glycolysis.
Low MP Cells Are Primed for Hypoxia Resistance
We performed a PCR array for hypoxia related gene expression
on freshly isolated high and lowMP cells. Under normoxic condi-
tions, the low MP cells displayed significant upregulation of
numerous hypoxia-inducible genes and regulatory glycolysis
genes (Figure 3A) compared to high MP cells. This was further
confirmed by upregulation and stabilization of Hif1-a protein
(RNA in Figure 3A and Figure S2A available online, and protein
in Figures 3B and 3C) in the low MP cells. These results not
only provide a mechanistic explanation of the metabolic pheno-
type of low MP cells but also suggest that the low MP cells are
primed for adaptation to low-oxygen environment. This was
corroborated by the significantly higher viability of low MP cells
following both severe hypoxic and anoxic stresses (Figure 3D).CellCollectively, these results indicate that cells in the lowMP gate
utilize glycolysis instead of mitochondrial respiration for their
energy demands. This metabolic phenotype is associated with
normoxic upregulation of Hif-1a and its downstream target
genes.
Stem Cell Characteristics of Metabolically Sorted Cells
Given the unique metabolic characteristics of LT-HSCs cells, we
tested whether isolation of bone marrow cells solely based on
their metabolism enriches for HSC. After flow cytometric separa-
tion of high and lowMP cells, we evaluated their gene expression
profile with PCR array. Figure 4A demonstrates that lowMP cells
express higher levels of numerous HSC-associated transcripts.
Furthermore, we utilized in vitro and in vivo hematopoietic
progenitor and HSC assays to characterize the stem cell proper-
ties of low MP cells. Low and high MP cells were cultured
in methocult medium and the colonies were evaluated after
12 days. Low MP cells displayed a much higher colony forming
capacity compared to high MP cells (Figure 4B). Further charac-
terization of colony types revealed that the lowMP cell produced
a higher percentage of CFU-GEMM type (mixed colonies) with
lower percentages of BFU-E and CFU-GM colonies compared
to high MP cells (Figures 4C–4E), although the low MP popula-
tion had significantly higher number of all types of colonies.
These results indicate that low MP cells are enriched for hema-
topoietic progenitor cells.
In vivo bonemarrow reconstitution studies following lethal irra-
diationwere undertaken to determine the long-term repopulation
capacity of low MP cells. Serial analysis of the peripheral blood
of the recipient mice demonstrated a significantly higher
percentage of engraftment with the low MP cells compared to
high MP cells at all time points (Figures 4F and 4G). Moreover,
peripheral blood cells were collected and analyzed by flow
cytometry with lineage markers to determine the capacity of
low MP cells to repopulate different hematopoietic lineages. As
shown in Figure S1A, the low MP cells repopulated all tested
lymphoid (CD45.2+Thy1.2+, CD45.2+B220+) and myeloid line-
ages (CD45.2+Mac-1+, CD45.2+Gr-1+). Additional studies were
undertaken in which the bone marrow was depleted of HSCs
by flow cytometric separation of LSK cells, followed by equal
distribution of LSK cells to the high and low MP populations.
Bone marrow reconstitution studies using these high and low
MP populations with equal numbers of HSCs demonstrated no
difference in transplantation efficiency (Figure S1B). This
confirms that the enhanced reconstitution capacity by the low
MP population is due to localization of LT-HSCs to the low MP
gate. Collectively, these results confirm that the lowMP cell frac-
tion of the bone marrow is highly enriched in both hematopoietic
progenitors and long-term repopulating HSCs.
Expression of Hif-1a in LT-HSCs
In order to determine the mechanism of the glycolytic metabolic
phenotype of LT-HSCs, we evaluated the expression pattern of
Hif-1a in LT-HSCs and WBM (Figure 5A). WBM and LT-HSCs
underwent fixation followed by permeabilization and immunocy-
tochemical staining for Hif-1a. Here, we show that the majority
(89%) of LT-HSCs express Hif-1a, whereas less than 30% of
the WBM cells are Hif-1a positive. Upregulation of Hif-1a
mRNA was confirmed by real-time PCR as shown in Figure S2B.Stem Cell 7, 380–390, September 3, 2010 ª2010 Elsevier Inc. 383
Figure 3. Normoxic Upregulation of Hif-1a in Low MP Cells
(A) Hypoxia real-time PCR array profile of low MP cells compared to high MP cells. Note the significant normoxic upregulation of hypoxia inducible genes in low
MP cells under normoxic conditions (5–6 hr after isolation).
(B) Upper panel(s) show western blot analysis of high and low MP cells with Hif-1a antibody and actin as loading control. The lower panel shows densitometry
analysis demonstrating higher Hif-1a protein expression in the low MP cells (n = 3).
(C) Immunocytochemistry staining demonstrating a higher percentage of low MP cells expressing Hif-1a compared to high MP cells (n = 3).
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Meis1 Regulates HSC MetabolismMeis1 Is a Transcriptional Activator of Hif-1a
Meis1 is a HSC-associated transcription factor required for
definitive hematopiesis; however, its precise role in HSCs is
not well understood. We determined that whereas only a small
percentage of WBM cells express Meis1 protein (1.4%), the
vast majority of LT-HSCs are Meis1 positive (96.2%) (Figure 5B).
Moreover, we colocalized Hif-1a andMeis1 proteins by immuno-
cytochemistry and found that the majority of Meis1 positive cells
were also positive for Hif-1a (85.2%) (Figure 5C). This expression
pattern of Hif-1a and Meis1 remained unchanged hours after
isolation of bone marrow cells, indicating that the expression
of Hif-1amay not be simply secondary to the in vivo environment
in the bone marrow.
These findings led us to examine whether Hif-1a expression
by LT-HSCs is downstream of the HSC-associated transcription
factor Meis1. We identified an evolutionarily conserved Meis1
consensus binding sequence in the Hif-1a first intronic region
(Figure 5D). Luciferase assays were carried out with wild-type
Hif-1a promoter (Hif1-a-pGL2) and a Hif-1a promoter harboring
a mutated Meis1 binding sequence (mut-TGAC-Hif-1a-pGL2).
Increasing concentrations of Meis1 expression vector (CMV-
M-Meis1) resulted in dose-dependent transcriptional activation
of Hif-1a. This activation was dependent on binding of Meis1
to its consensus binding sequence in the Hif-1a first intronic
region because mutation of the seed sequence completely abol-
ished the activation of Hif-1a by Meis1 (Figure 5E).
To determine whether Meis1 is required for Hif-1a expression,
we utilized siRNA to knockdown Meis1 in freshly isolated
LT-HSCs. Scrambled Meis1 siRNA was used as control. Trans-
fection with Meis1 siRNA resulted in diminution of Meis1 mRNA
levels. This was associated with a marked downregulation of
Hif-1a mRNA (Figure 5F). Taken together, these results indicate
that Meis1 is required for optimal transcriptional activation of
Hif-1a in LT-HSCs.
To confirm the in vivo binding of Meis1 to its conserved
sequence in the Hif-1a gene, we performed chromatin immuno-
precipitation (ChIP) assays in Kasumi1 cells. The results con-
firmed that Meis1 binds in vivo to its conserved sequence in
the Hif-1a first intronic region as determined by real-time PCR
following immunoprecipitation with Meis1 antibody (Figure 5H).
PCR products are shown in the right panel.DISCUSSION
Stem cell separation techniques generally rely on the pattern of
expression of specific membrane proteins. As a result, isolation
of HSCs requires the combination of several antibodies such that
stem cells are defined by the presence or absence of certain
epitopes or markers (Challen et al., 2009; Goodell et al., 1996;
Kiel et al., 2007; McCune et al., 1988; Murray et al., 1995; Pe´ault
et al., 1993). Although several reports have indicated that HSCs
are resistant to hypoxia (Cipolleschi et al., 1993) and reside
within hypoxic niches in the bone marrow (Chow et al., 2001b;(D) Viability of low and high MP cells followed low-oxygen stress. The left panel s
hypoxia. The right panel shows the percentage of viable low and high MP cells
significantly higher viability in the low MP population after both hypoxia and ano
See also Figure S2.
CellLi and Li, 2006; Parmar et al., 2007), these characteristics have
not been exploited for identification of unique metabolic proper-
ties of HSCs, or for HSC enrichment.
In the current study, we define the metabolic phenotype of
mouse HSCs. We demonstrate that LT-HSCs cells are localized
to a distinct population of cells characterized by low mitochon-
drial potential (low MP). This population represents only 6%–
9% of the total bone marrow, but contains >80% of LT-HSCs,
determined by surface marker expression. We show that both
LT-HSCs and low MP cells have low ATP levels and utilize
cytoplasmic glycolysis instead of mitochondrial oxidative phos-
phorylation. This metabolic phenotype is associated with upre-
gulation of Hif-1a, at both the transcript and the protein levels.
Separation of cells solely based on this metabolic profile mark-
edly enriches for HSCs as determined by in vitro colony forming
assays and in vivo long-term repopulation assays. Finally, we
show that the HSC-associated transcription factor Meis1
regulates HSC metabolism through transcriptional activation of
Hif-1a.
Hif-1a is a master regulator of metabolism known to regulate
various aspects of cellular response to hypoxic stress. Although
the mechanism of oxygen-dependent posttranslational regula-
tion of Hif-1a is well understood, little is known about its tran-
scriptional regulation. A number of reports indicate that Hif-1a
is regulated at the transcriptional level both during hypoxia
and normoxia (Belaiba et al., 2007; Blouin et al., 2004; Hirota
et al., 2004; Jiang et al., 1997; Laughner et al., 2001; Liu
et al., 2004). In the current study, we show that Meis1 activates
Hif-1a transcription in LT-HSCs through binding to its
conserved consensus binding sequence in the Hif-1a first in-
tronic region.
The metabolic phenotype of HSCs outlined here is supportive
of the adaptability of HSCs to the physiologic low-oxygen
tension in the bonemarrow hypoxic niches. Under these hypoxic
conditions, glycolytic metabolism predominates and can
provide sufficient amounts of ATP to sustain HSCs. This meta-
bolic phenotype also confers a survival advantage on HSCs
during severe hypoxic or anoxic insults that would invariably
eliminate differentiated cells that rely on oxidative metabolism.
Importantly, the transcriptional regulation of Hif-1a by Meis1
highlights the involvement of stem cell-associated transcription
factors in regulation of HSC metabolism and indicates that the
glycolytic phenotype of HSCs is not merely a product of their
hypoxic environment.EXPERIMENTAL PROCEDURES
LT-HSC Isolation
LT-HSCs were isolated from the bone marrow cells of 4- to 6-month-old
C57BL/6 mice by FACS after surface marker staining for Lin, Sca-1, C-Kit,
CD34, and Flk2 to identify Lin, Sca-1+ C-kit+, and CD34/Flk2 cells (LT-
HSCs). All antibodies were purchased from BD PharMingen. In studies where
LT-HSCs were isolated for metabolic analysis, magnetic lineage depletion
(autoMACS separator, Miltenyibiotec) was utilized. In these studies, additionalhows the percentage of viable low and high MP cells after 12 hr of severe (1%)
after 12 hr of anoxia (n = 3). Viability was assessed with trypan blue. Note the
xia. Data presented as mean ± SEM.
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Figure 4. Low MP Cells Are Enriched for HSCs
(A) PCR array profile of low MP cells compared to high MP cells demonstrating enrichment of a number of HSCs associated genes in the low MP population.
(B) The left panel shows a representative bright field microscopic image of colonies obtained from low and high MP cells. The right panel shows quantification of
colonies derived from low and high MP cells in methocult after 12 days.
(C) GFU-GEMM colonies.
(D) CFU-GM colonies.
(E) BFU-E colonies (n = 3). Note the significantly higher number of colonies derived from the lowMP population. These results indicate that the lowMP population
is markedly enriched for hematopoietic progenitor cells.
(F) Representative flow cytometry profiles of peripheral blood of bone marrow recipient mice after staining with anti-CD45.2-FITC antibody (x axis) and anti-
CD45.1-PE antibody (y axis), demonstrating higher engraftment in the recipient of low MP cells.
(G) Time course analysis of bone marrow reconstitution with low and high MP cells (n = 5 animals/group). Note the significantly higher bone marrow repopulation
capacity of the low MP cells at all time points. This result indicates that the low MP population is enriched for long term repopulating HSCs. Data presented as
mean ± SEM.
See also Figure S1.
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Meis1 Regulates HSC Metabolismcontrol fluorescent surface marker staining was performed, and the cells were
evaluated by flow cytometry for ensuring that adequate lineage depletion
(>95% lineage depletion) was reproducibly achieved. For metabolic studies,
LT-HSCs isolated from 62 mice were pooled, and metabolic studies were per-
formed within 24 hr of isolation.
Metabolic Assays
Oxygen consumption was measured with the BD Oxygen Biosensor System
in accordance with the manufacturer’s recommendations. A total of 2 to
3 3 105 cells/well were used. Oxygen consumption was determined after
2 hr of culture in the biosensor.386 Cell Stem Cell 7, 380–390, September 3, 2010 ª2010 Elsevier InATP levels were quantified with ATP Bioluminescence Assay Kit HS II
(Roche) in accordance with the manufacturer’s recommendations. A total of
2 to 3 3 105 cells/well were used.
Lactate production was measured with gas chromatography-mass
spectrometry. Cells were cultured for 12 hr in a medium supplemented with
10 mM D-[1-13C]-glucose (Cambridge Isotope Labs) to allow up to half of
the glucose-derived lactate pool to be labeled on C-3. The samples were
analyzed for lactate abundance. The final results are presented as nMoles
13C-Lactate/nMol ATP.
Mitochondrial source of NADH was determined with the electron transport
chain complex III inhibitor antimycin A (AMA). AMA leads to cessation of electronc.
Figure 5. Transcriptional Regulation of Hif-1a by Meis1
(A) Expression pattern of Hif-1a. The left panel shows expression of Hif-1a in WBC. The middle panel shows expression of Hif-1a in LT-HSCs. The right panel
shows quantification of Hif-1a expression. Note that whereas less than 25% of the unfractionated bone marrow cells express Hif-1a, the vast majority of LT-
HSCs express Hif-1a protein (n = 3).
(B) Expression pattern of Meis1. The left panel shows expression of Meis1 in WBM. The middle panel shows expression of Meis1 in LT-HSCs. The right panel
shows quantification of Meis1 expression. Note that whereas less than 2% of the unfractionated bone marrow cells express Meis1, almost all the LT-HSCs
express Meis1 protein (n = 3).
(C) Colocalization of Hif-1a and Meis1 in the WBM. The left panel shows a representative flow cytometry profile of the expression of Hif-1a and Meis1. The right
panel shows quantification of Hif-1a andMeis1 expression. Note that although only a small percentage of WBM cells expressMeis1, the majority of theseMeis1+
cells also coexpress Hif-1a (n = 3).
(D) Schematic of the conserved Meis1 binding domain in the first intronic region Hif-1a.
(E) Luciferase assay demonstrating dose dependent increase in Hif-1a luciferase activity after transfection with Meis1 expression vector. Mutation of the four
nucleotides Meis1 seed region completely abolishes the luciferase activity (n = 3).
(F) Real-time PCR following siRNA knockdown ofMeis1 in freshly isolated LT-HSCs. Knockdown of Meis1 in LT-HSCs (5.6-fold) resulted in marked downregu-
lation of Hif-1a mRNA levels (4.5-fold), (n = 3).
(G) ChIP assay demonstrating in vivo binding ofMeis1 to its consensus binding sequence in theHif1-a first intron. The left panel shows real-time PCRwith primers
flanking the consensus Meis1 binding sequence compared to control IgG after immunoprecipitation. The right panel shows PCR products showing input control
and negative amplicon (n = 3). Data presented as mean ± SEM.
See also Figure S2.
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Meis1 Regulates HSC Metabolismflow through the respiratory chain resulting in rapid accumulation of NADH from
the Krebs cycle. Stock AMA (Sigma Aldrich) was prepared at 1 M in DMSO. A
baseline NADH fluorescence gate was set with untreated high and lowMP cells.CellHigh and lowmitochondrial potential cells were then treatedwith 2 mMAMA for 5
minandprofiled forNADHfluorescence.Cellswithmitochondrial sourceofNADH
production display an increase in NADH fluorescence following AMA treatment.Stem Cell 7, 380–390, September 3, 2010 ª2010 Elsevier Inc. 387
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Meis1 Regulates HSC MetabolismFlow Cytometric Profiling and Separation of Cells Based
on Mitochondrial Activity
Flow cytometric profiling and separation of BM cells based on their mitochon-
drial activity was performed with mitotracker dyes and endogenous NADH
fluorescence. The metabolic profile of mouse LT-HSCs was determined with
concomitant surface marker and mitotracker staining. Mitotracker dyes that
accumulate within mitochondria on the basis of mitochondrial proton gradient
(MitoTracker deep red 633, MitoTracker Red CMXRos and MitoTracker Red
CM-H2XRos) (Poot et al., 1996), as well as nonproton gradient sensitive
dyes (MitoTracker Green), were used. Endogenous NADH fluorescence was
measured flow cytometrically at 37C with a UV laser (Ex: 350 nm, Em:
460 nm, Moflo analyzer, Cytomation) as described previously (Chance and
Thorell, 1959). Flow cytometric separation of high and lowMP cells was carried
out by separating cells in the low MP gate (6%–9%) and an equivalent number
of cells with high mitochondrial potential.
Stem Cell Assays
Colony forming cell (CFC) assays were performed on high and low MP cells
separated solely on the basis of the flow cytometric mitochondrial profile
according to recommendations (Methocult, Stem Cell Technologies). For
in vivo bone marrow reconstitution studies, high and low MP cells were iso-
lated from 8- to 10-week-old C57BL/6 CD45.2 mice. Equal numbers of high
and low MP CD45.2 donor cells (53 104) were mixed with 53 104 freshly iso-
lated CD45.1 competitor bone marrow cells, and the mixture was injected
intravenously via the retro-orbital route into each of a group of 6- to 9-week-
old CD45.1mice previously irradiatedwith a total dose of 10Gy. Formeasuring
reconstitution of transplanted mice, peripheral blood was collected at the indi-
cated times after transplant and the presence of CD45.1+ and CD45.2+ cells in
lymphoid and myeloid compartments were measured as described (Zhang
and Lodish, 2004, 2005). Separate studies were performed were LSK cells
were depleted from the bone marrow by flow cytometry, followed by equal
distribution of LSK cells to high and low MP populations (1500 LSK cells
per group). CD45.2 high and low MP donor cells (5 3 104) were mixed with
5 3 104 freshly isolated CD45.1 competitor bone marrow cells.
Gene Profile of Low and High MP Cells
RNA was extracted from high and low MP cells by using TRIzol (Invitrogen) in
accordance with the manufacturer’s instructions. cDNA was retrotranscribed
with an RT-PCR kit (SA Biosciences). Mouse Real-Time Syber Green PCRMix
was purchased from SuperArray. PCR was performed on an ABI Prism 7700
Sequence Detector (Applied Biosystems). HSCs and hypoxia primer sets
(SABiosciences) were used. The data were analyzed with the DDCt method.
Fold change was calculated as difference in gene expression between high
and low MP cells. Additional real-time PCR for Meis1, Hif-1a was performed
with the SyberGreen method (Applied Biosystems) on ABI Prism 7700
Sequence Detector (Applied Biosystems) and primers specific for the selected
genes.
Intracellular Detection of Hif-1a and Meis1 Proteins
Hif-1a by Meis1 proteins were detected by immunocytochemistry as follows;
fresh bone marrow cells underwent fixation with 4% paraformaldehyde for
10 min at room temperature. After permeabilization (0.01% Triton) and
serum block, cells were incubated overnight with primary antibodies (1:50 dilu-
tion anti-Hif-1a and 1:50 dilution anti-Meis1). Staining was assessed by
flow cytometry after incubation with corresponding fluorophore-conjugated
secondary antibody.
Transcriptional Activation of Hif-1a by Meis1
Luciferase reporter assay was performed with an 818 bp long DNA fragment
from the first intronic region of Hif-1a containing the conserved Meis1 binding
site (+1799 bp from ATG start site, chr14:61,232,973-61,233,790) was ampli-
fied frommouse genomic DNA and used for generation of TGAC-Hif-1a-pGL2
and mut-TGAC-Hif-1a-pGL2 reporter vectors. Transcriptional activation of
Hif-1a by Meis1 was evaluated with Hif-1a-pGL2 and mut-TGAC-Hif-1a-
pGL2 vectors.
Meis1 siRNA knockdown was carried out in freshly isolated LT-HSCs
(4 3 104 cells/reaction). Cells were transfected with 50 nM of Silencer Select
Custom-designed siRNA corresponding to Meis1 (#s237712), and nontarget-388 Cell Stem Cell 7, 380–390, September 3, 2010 ª2010 Elsevier Ining control siRNA (Silencer Select Negative Control #1 siRNA, Applied Biosys-
tems). Transfections were performed with the Amaxa Nucleofector device
(program Y-001) with Amaxa CD34+ Cell Nucleofector Kit (Lonza Cologne
AG) in accordance with the manufacturer’s instructions. After incubation at
37C for 20 hr, transfected LT-HSCs cells were harvested and analyzed by
real-time PCR with Meis1 and Hif-1a primers.
ChIP assay was performed to evaluate the in vivo binding of Meis1 to its
consensus sequence in the Hif-1a enhancer region. The assays were done
using the ChIP kit (Upstate, cat#17-295) according to the manufacturer’s
instructions. Meis1 polyclonal antibody (Santa Cruz, cat# sc-10599) was
utilized.
Statistical Analysis
Significance levels were calculated with a Student’s t test.
SUPPLEMENTAL INFORMATION
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